Skip to content

Effect of PRF as a complementary therapy in the treatment of periodontal disease

Effect of PRF as adjunctive therapy to scaling and root planing in the treatment of periodontitis - PRF - Platelet Rich Fibrin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-52h647m
Enrollment
Unknown
Registered
2022-03-02
Start date
2022-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Pocket

Interventions

First Objective: To evaluate the effect of i-PRF as an adjuvant therapy to Scaling and Root Planing (SRP) in Non-Surgical Periodontal Therapy (NCPT) of patients diagnosed with periodontitis. Second Ob
Clinical analysis time (repeated measure) at three levels (Baseline - before periodontal therapy, forty-five days after periodontal therapy and ninety days after periodontal therapy)
Two-level radiographic analysis time (Baseline - before periodontal treatment and ninety days after periodontal therapy) Response variables: Plaque index (PI), probing pocket depth (PS), gingival rece
levels of cytokines IL-1ß, TNF-a and IL-10 Methods of analysis: Clinical periodontal examination, radiographic and collection of crevicular gingival fluid Sample Size: Thirty patients The randomizatio
Clinical analysis time (repeated measure) at three levels (Baseline - before periodontal treatment, forty-five

Sponsors

Faculdade de Odontologia da Universidade Federal de Uberlândia
Lead Sponsor
Faculdade de Odontologia - Universidade Federal de Uberlândia
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with Stage III Periodontitis, with 5 mm or more of interproximal attachment loss or radiographic bone loss extending to the apical half or third of the root; may have vertical bone loss of up to 3 mm; grade II or III furcation lesions and moderate ridge defect; direct evidence of non-progression of attachment loss for 5 years or indirect evidence of bone loss/year up to 0.25 mm; patients with large accumulation of biofilm but little periodontal destruction; minimum of 20 teeth present and presence of two pairs of contralateral teeth with proximal periodontal sites presenting probing depth and clinical attachment level = 5 mm

Exclusion criteria

Exclusion criteria: Underage patients; patients who do not agree with the informed consent and do not sign it; tooth loss of 5 or more teeth due to periodontitis; positive history of antibiotic therapy in the last six months; positive history of nonsurgical periodontal therapy in the last six months; systemic involvement that may interfere with disease progression or response to treatment; need for antibiotic prophylaxis for routine dental procedures; use of anti-inflammatory drugs for a long period of time; smoking; pregnancy

Design outcomes

Primary

MeasureTime frame
To evaluate the plaque index on dental surfaces, which will be verified by the percentage of tooth surfaces with plaque deposits stained with evidencing solution and it is expected to find a reduction in this plaque index;To evaluate the pocket depth on probing, which will be verified using a periodontal probe, after 90 days of non-surgical periodontal therapy, it is expected to find a reduction in this probing, with an expected depth equal to or less than 3 mm

Secondary

MeasureTime frame
To assess the presence of bleeding on probing, which will be verified at the time of probing with the use of the periodontal probe, it is expected that, after 90 days of non-surgical periodontal therapy, there will be no bleeding on probing

Countries

Brazil

Contacts

Public ContactPriscilla Soares

Faculdade de Odontologia - Universidade Federal de Uberlândia

pbfsoares@yahoo.com.br+55(034) 99770088

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 4, 2026